Submit your email to push it up the queue
Arolys Singapore Pte Limited, commonly referred to as Arolys, is a prominent player in the biotechnology and life sciences industry, headquartered in Singapore (SG). Founded in 2015, the company has rapidly established itself as a leader in innovative solutions for healthcare and pharmaceuticals, with a strong operational presence across Southeast Asia. Arolys specialises in the development of cutting-edge biopharmaceuticals and diagnostic tools, focusing on enhancing patient outcomes through advanced technology. Their unique approach combines rigorous research with a commitment to quality, setting them apart in a competitive market. With a reputation for excellence, Arolys has achieved significant milestones, including partnerships with leading research institutions and recognition for its contributions to the field. As a forward-thinking organisation, Arolys continues to drive advancements in biotechnology, positioning itself as a trusted name in the industry.
How does Arolys Singapore Pte Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Arolys Singapore Pte Limited's score of 27 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Arolys Singapore Pte Limited, headquartered in Singapore (SG), currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of Fraser and Neave, Limited, which may influence its climate commitments and reporting practices. As part of its corporate family, Arolys inherits emissions data and sustainability initiatives from Fraser and Neave Holdings Bhd, which operates at a cascade level of 1. However, specific reduction targets or achievements for Arolys are not detailed in the available information. The company does not have documented reduction targets under the Science Based Targets initiative (SBTi) or any other climate pledges. This lack of specific commitments suggests that Arolys may still be in the early stages of developing its climate strategy. In summary, while Arolys Singapore Pte Limited is part of a larger corporate structure with potential access to sustainability initiatives, it currently lacks specific emissions data and defined climate commitments.
Access structured emissions data, company-specific emission factors, and source documents
2017 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|
Scope 1 | 12,666,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
Scope 2 | 12,772,000 | 00,000,000 | 0,000,000 | 00,000,000 | 0,000,000 | 00,000,000 |
Scope 3 | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Arolys Singapore Pte Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.